Main Article Content
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Federico A, Dallio M, Masarone M, Persico M, Loguercio C. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. Eur Rev Med Pharmacol Sci. 2016;20(22):4731-4741. PMID: 27906428.
Fan Y, Wei F, Zhou Y, Zhang H. Association of non-alcoholic fatty liver disease with impaired endothelial function by flow-mediated dilation: A meta-analysis. Hepatol Res. 2016;46(3):165-73. doi: 10.1111/hepr.12554.
Ambrosino P, Lupoli R, Iervolino S, et al. Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med. 2017. doi: 10.1007/s11739-017-1690-0.
Gonzalez-Paredes FJ, Hernández Mesa G, Morales Arraez D, et al. Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease. PLoS One. 2016;11(5):e0156650. doi: 10.1371/journal.pone.0156650.
Polverino F, Laucho-Contreras ME, Petersen H, et al. A Pilot Study Linking Endothelial Injury in Lungs and Kidneys in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017 Jun 1;195(11):1464-1476. doi: 10.1164/rccm.201609-1765OC.
Lebed' KN. Markers of systemic inflammation in patients with chronic obstructive pulmonary disease associated with non-alcoholic steatohepatitis. Problemy ekolohichnoi ta medychnoi henetyky i klinichnoi imunolohii. 2012;3:200-204. (in Russian).
Lebed' KN. Peroxide lipid oxidation and state of the system of antioxidant protection in patients with chronic obstructive pulmonary disease combined with nonalcoholic steatohepatitis. Ukrainskyi medychnyi almanakh. 2013;16(1):138-141. (in Ukrainian).
Jung DH, Shim JY, Lee HR, Moon BS, Park BJ, Lee YJ. Relationship between non-alcoholic fatty liver disease and pulmonary function. Intern Med J. 2012 May;42(5):541-6. doi: 10.1111/j.1445-5994.2011.02644.x.
Mapel DW, Marton JP. Prevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPD. Int J Chron Obstruct Pulmon Dis. 2013;8:127-34. doi: 10.2147/COPD.S40123.
Peng TC, Kao TW, Wu LW, et al. Association between pulmonary function and nonalcoholic fatty liver disease in the NHANES III study. Medicine (Baltimore). 2015 May;94(21):e907. doi: 10.1097/MD.0000000000000907.
Qin L, Zhang W, Yang Z, et al. Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese. BMC Endocr Disord. 2017 Mar 22;17(1):18. doi: 10.1186/s12902-017-0168-4.
Lefere S, Van de Velde F, Devisscher L, et al. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. Int J Obes (Lond). 2017;41(8):1207-1213. doi: 10.1038/ijo.2017.102.
Federico A, Dallio M, Masarone M, Persico M, Loguercio C. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. Eur Rev Med Pharmacol Sci. 2016;20(22):4731-41. PMID: 27906428.